The SPC blog reports today on a decision from the Court of Justice of the EU in a reference from Lithuania in a case regarding Kirin Amgen's drug Aranesp.
As blogger Jeremy Phillips explains, the Court ruled in favour of giving new EU member states discretion over transitional provisions.